BIOTECH (169) Insilico Medicine: INS018_055 – the first generative-AI drug at phase 2 clinical trials April 4, 2024April 4, 2024
PRODUCTIVE LONGEVITY (9) Peter Drucker, SOAR, and Maximizing the Second Half of Life by Bruce Rosenstein April 4, 2024April 4, 2024
BIOTECH (165) Themis Bioscience GmbH: Merck’s wholly-owned subsidiary – Recombinant Measles Vector Vaccine Platform April 1, 2024April 1, 2024
BIOTECH (164) Omega Therapeutics: Insulated Genomic Domain (IGD) Platform – Controllable Epigenomic Programming Platform April 1, 2024April 1, 2024